Epigenetics Pharma
Manufacturing · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9270 SE 36th Pl, Mercer Island, Washingt...Phone Number
(206) 390-3895Website
www.epigeneticspharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Epigenetics Pharma
Epigenetics Pharma specializes in developing innovative cancer treatments by upregulating tumor suppressor genes and enhancing the antitumor immune response. Their lead products, iMN013 and its prodrug iMN041, are designed to effectively target solid tumors, including triple negative breast cancer and pancreatic cancer, by utilizing the patient's own immune system. The company aims to address the limitations of existing therapies through a unique combination of DNA methyl transferase inhibition and ribonucleotide reductase inhibition. With a focus on immunotherapy, Epigenetics Pharma is advancing its products towards clinical testing to improve outcomes for cancer patients.Explore more
Popular SearchesEpigenetics PharmaEpigenetics Pharma LLCEpigeneticspharmaSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epigenetics Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Epigenetics Pharma recently announced quarterly report
Product Launch: Get notified when Epigenetics Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Epigenetics Pharma
Check out if Epigenetics Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Epigenetics Pharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Epigenetics Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Epigenetics Pharma has new funding data
Website visits: Recent activity has been detected on your website
Epigenetics Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Epigenetics Pharma
Compare insights from companies similar to Epigenetics Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Epigenetics Pharma
<$5M
1-10
Private
-
2014
N/A
Company Profile Activity
Activity Insights
Epigenetics Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Epigenetics Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Epigenetics Pharma.
Epigenetics Pharma Tech Stack
A closer look at the technologies used by Epigenetics Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epigenetics Pharma
Sign Up For FreeTo access detailed company insights
Epigenetics Pharma specializes in developing innovative cancer treatments by upregulating tumor suppressor genes and enhancing the antitumor immune response. Their lead products, iMN013 and its prodrug iMN041, are designed to effectively target solid tumors, including triple negative breast cancer and pancreatic cancer, by utilizing the patient's o... Read More
